A newly released peer-reviewed study from Italy raises serious concerns about the safety of COVID-19 vaccines, challenging the narratives promoted by pharmaceutical companies and health authorities. This expansive study tracked nearly 300,000 individuals in Pescara province over 30 months, presenting findings that could have far-reaching implications for public health.
The research focused on residents aged 11 and older, correlating vaccination status with hospital records. While the authors noted that vaccinated individuals had a lower overall risk of dying from any cause, the results were more troubling when examining cancer diagnoses. Specifically, researchers found concerning links between the vaccines and increased risks of various cancers.
Those vaccinated showed a troubling trend toward higher hospitalization rates for new cancer diagnoses compared to their unvaccinated counterparts. This was especially pronounced in cases of breast, bladder, and colorectal cancers. Importantly, this elevated risk was noted primarily in individuals who had not previously contracted COVID-19. Alarmingly, when examining cases over a longer interval—at least twelve months after vaccination—the risk either lessened or even turned negative.
Data indicated that cancer hospitalizations were 35% higher in vaccinated people, a stark contrast to the expectations fostered by the “healthy vaccinee bias.” This phenomenon suggests that vaccinated individuals generally have healthier lifestyles, making the increased cancer rates particularly concerning. “If anything, the numbers should have shown lower cancer rates,” researchers pointed out, emphasizing the disconnect between anticipated outcomes and reality.
Quantifying the cancer risks reveals significant numbers. After just one vaccine dose, overall cancer risk rose by 23%. For specific cancers, the risks increased dramatically—breast cancer risk surged by 54%, bladder cancer by 62%, and colorectal cancer by 35%. Even with multiple doses, these risks remained elevated. The authors expressed alarm over how these findings suggest a potentially critical health issue that might be overshadowed by prevalent biases in health data interpretation.
Furthermore, medical professionals and whistleblowers have long warned about the emergence of aggressive cancers following vaccination. This study aligns with over 100 other peer-reviewed papers documenting these disturbing patterns, leading to the categorization of a new medical term: COVID-19 Vaccine-Induced “Turbo Cancer.” This terminology underscores the urgency and seriousness of the findings.
The study’s strongest signals indicated significant increases in breast, bladder, and colorectal cancers, suggesting that the risks could be even more profound than the data indicates. While statistically significant increases were observed in certain cancers, other cancers also showed upward trends, hinting at a broader, yet less clear, risk association.
Given the scale of this study and its implications, health authorities and the public must reconsider the narratives previously articulated about the vaccines’ safety and effectiveness. The interplay between vaccination and long-term health outcomes—particularly concerning cancer—deserves rigorous examination and transparency. As new research emerges, it’s critical to maintain an open dialogue and a commitment to truth in health communication.
"*" indicates required fields